Black Diamond Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Black Diamond Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.08M, a 2.76% increase year-over-year.
  • Black Diamond Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $4.24M, a 44.6% increase from 2022.
  • Black Diamond Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $2.94M, a 19.1% increase from 2021.
  • Black Diamond Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $2.46M, a 470% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.24M +$1.31M +44.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $2.94M +$471K +19.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $2.46M +$2.03M +470% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $432K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.